K2 Principal Fund’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-45,000
| Closed | -$790K | – | 441 |
|
|
2021
Q3 | $790K | Buy |
+45,000
| New | +$790K | 0.06% | 148 |
|
|
2017
Q3 | – | Sell |
-60,013
| Closed | -$264K | – | 317 |
|
|
2017
Q2 | $264K | Buy |
+60,013
| New | +$264K | 0.02% | 197 |
|
|
2017
Q1 | – | Sell |
-16,239
| Closed | -$92K | – | 291 |
|
|
2016
Q4 | $92K | Buy |
+16,239
| New | +$92K | 0.01% | 151 |
|
|
2016
Q3 | – | Sell |
-14,614
| Closed | -$131K | – | 243 |
|
|
2016
Q2 | $131K | Buy |
+14,614
| New | +$131K | 0.02% | 154 |
|
|
2015
Q1 | – | Sell |
-19,783
| Closed | -$178K | – | 155 |
|
|
2014
Q4 | $178K | Buy |
+19,783
| New | +$178K | 0.04% | 88 |
|